SSO1 Antibody

What is SSO1 and what is its biological function?

SSO1 is a protein (UniProt Number P32867) found in Saccharomyces cerevisiae (baker's yeast), specifically strain ATCC 204508/S288c . It functions as a SNARE (Soluble NSF Attachment protein REceptor) protein involved in vesicle fusion processes. SSO1 is part of the machinery that facilitates membrane fusion during vesicle trafficking in yeast systems.

The protein appears to have functional relationships with other SNARE complex members, as evidenced by research involving vesicle fusion mechanisms . Its role is particularly important in studies examining intracellular transport and protein secretion pathways in yeast, making SSO1 antibodies valuable tools for researchers investigating these fundamental cellular processes.

What types of SSO1 antibodies are currently available for research applications?

Currently, polyclonal SSO1 antibodies raised in rabbits are commercially available for research use. These antibodies are typically generated using recombinant Saccharomyces cerevisiae SSO1 protein as the immunogen and purified using Protein A/G affinity chromatography . The most commonly referenced SSO1 antibody in the literature has the product code CSB-PA330206XA01SVG .

What are the validated applications for SSO1 antibodies?

Based on manufacturer specifications and research applications, SSO1 antibodies have been validated for:

• Western blotting (WB): For detection of native and recombinant SSO1 protein

• Enzyme-linked immunosorbent assay (ELISA): For quantitative determination of SSO1 in solution

• Detection of protein A (PrA) tagged fusion proteins: Used as a detection reagent for PrA-tagged proteins in fusion protein studies

The application versatility of these antibodies makes them useful across different experimental contexts in yeast biology research. When using these antibodies for purposes beyond these validated applications, researchers should perform thorough validation experiments to confirm their functionality in new contexts.

How can SSO1 antibodies be used to study SNARE complex assembly in yeast?

SSO1 antibodies can serve as valuable tools for investigating SNARE complex assembly through several sophisticated approaches:

Co-immunoprecipitation studies: Researchers can use SSO1 antibodies to pull down SSO1 along with its interaction partners to study complex formation dynamics. This approach allows for the identification of proteins that interact with SSO1 under various experimental conditions, such as during different stages of vesicle fusion or in response to specific cellular stressors.

Temporal analysis of complex formation: By employing SSO1 antibodies in time-course experiments, researchers can monitor the sequential recruitment of SNARE proteins during complex assembly. This method provides insights into the kinetics and regulation of SNARE-mediated membrane fusion.

Analysis of mutant phenotypes: SSO1 antibodies can be particularly useful for comparing SNARE complex formation between wild-type and mutant yeast strains. Similar to studies of Vps45 mutations that affect SNARE interactions in vesicle fusion processes , researchers can use SSO1 antibodies to detect alterations in complex formation that result from specific mutations.

A methodologically sound approach would involve:

• Preparation of yeast lysates under non-denaturing conditions to preserve protein-protein interactions

• Immunoprecipitation with SSO1 antibodies coupled to a solid support

• SDS-PAGE separation of precipitated proteins

• Western blot analysis using antibodies against potential interaction partners

• Control experiments using pre-immune serum to establish specificity

What considerations are important when using SSO1 antibodies for protein localization studies?

When employing SSO1 antibodies for immunofluorescence or immunoelectron microscopy to study protein localization, researchers should consider:

Fixation methods: The choice between crosslinking fixatives (like paraformaldehyde) and precipitating fixatives (like methanol) can significantly impact epitope accessibility. Testing multiple fixation protocols is advisable for optimizing SSO1 detection.

Permeabilization conditions: Yeast cell walls require special consideration. Researchers should optimize spheroplasting procedures or permeabilization methods to ensure antibody access while maintaining cellular architecture.

Epitope masking: Interactions between SSO1 and other SNARE proteins may mask antibody epitopes in certain cellular compartments. Using antibodies that recognize different regions of SSO1 can help address this limitation.

Validation approaches:

• Parallel staining of wild-type and sso1Δ deletion strains

• Correlation with GFP-tagged SSO1 localization patterns

• Co-localization with established markers of cellular compartments

• Use of pre-immune serum as a negative control

How can SSO1 antibodies be used in studies of homologous proteins across different yeast species?

SSO1 antibodies may exhibit cross-reactivity with homologous proteins in related yeasts, particularly within the Saccharomycetaceae family. This cross-reactivity can be leveraged for comparative studies, but requires careful validation:

Cross-reactivity validation protocol:

• Perform sequence alignment of SSO1 homologs across target species

• Test antibody reactivity using Western blot analysis of lysates from different species

• Confirm specificity using genetic knockouts or knockdowns when available

• Validate using recombinant proteins expressed in heterologous systems

For experiments specifically studying homologous proteins in other yeast species such as Ashbya gossypii (where related SNARE proteins have been documented ), researchers should first confirm cross-reactivity and then determine the optimal working conditions for each species system.

What are the optimal conditions for Western blot analysis using SSO1 antibodies?

The following protocol has been optimized based on research practices and manufacturer recommendations:

Sample preparation:

• Extract proteins from yeast using mechanical disruption (glass beads) in lysis buffer containing protease inhibitors

• Include 1% Triton X-100 in lysis buffer to solubilize membrane-associated SSO1

• Heat samples at 70°C for 10 minutes rather than boiling to avoid aggregation of membrane proteins

Electrophoresis and transfer conditions:

• Use 10-12% SDS-PAGE gels for optimal resolution of SSO1 (~33 kDa)

• Transfer to PVDF membranes at 100V for 1 hour in transfer buffer containing 20% methanol

• Verify transfer efficiency using reversible protein staining before immunodetection

Immunodetection parameters:

• Blocking: 5% non-fat dry milk in TBST for 1 hour at room temperature

• Primary antibody: Dilute rabbit anti-SSO1 antibody 1:1000 in blocking buffer, incubate overnight at 4°C

• Washing: 4 × 5 minutes with TBST

• Secondary antibody: Anti-rabbit IgG-HRP at 1:5000 for 1 hour at room temperature

• Develop using enhanced chemiluminescence with 5-second exposure time

Optimization tips:

• For weaker signals, extend the primary antibody incubation time rather than increasing concentration

• Consider using more sensitive detection methods (e.g., amplified chemiluminescence) for low abundance proteins

• For highly specific detection, perform antigen competition assays using the recombinant immunogen protein that comes with the antibody

What controls should be included when using SSO1 antibodies to ensure experimental validity?

A robust experimental design involving SSO1 antibodies should include the following controls:

Implementing these controls systematically allows researchers to accurately interpret their results and confidently attribute signals to specific SSO1 detection.

How should SSO1 antibody concentration be optimized for different experimental applications?

Antibody optimization is a critical step for achieving reliable results across different applications. The following table provides starting points and optimization approaches:

For each new application or experimental system, researchers should perform preliminary optimization experiments to determine the ideal antibody concentration that maximizes specific signal while minimizing background.

Why might Western blots with SSO1 antibodies show multiple bands, and how can specificity be confirmed?

The detection of multiple bands in Western blots using SSO1 antibodies could result from several factors:

Potential causes and solutions:

• Post-translational modifications:

  • SSO1 may undergo phosphorylation, ubiquitination, or other modifications

  • Solution: Treat samples with phosphatases or deubiquitinating enzymes to determine if bands merge

• Protein degradation:

  • Partial proteolysis during sample preparation

  • Solution: Use fresher samples, increase protease inhibitor concentration, reduce sample processing time

• Splice variants or isoforms:

  • Though less common in yeast, protein isoforms can exist

  • Solution: Compare observed bands with predicted molecular weights of known isoforms

• Cross-reactivity with homologous proteins:

  • Antibodies may detect related SNARE proteins

  • Solution: Compare band patterns in wild-type vs. knockout strains

Confirmation of specificity approaches:

• Genetic validation:

  • Compare Western blots of wild-type and sso1Δ strains

  • If the band disappears in the deletion strain, it confirms specificity

• Immunogen competition assay:

  • Pre-incubate antibody with excess recombinant SSO1 immunogen provided in the antibody kit

  • Specific bands should disappear while non-specific bands remain

• Mass spectrometry validation:

  • Excise bands of interest and perform mass spectrometry analysis

  • Compare peptide signatures with SSO1 sequence

What steps can be taken when SSO1 antibodies fail to detect expected signals in experimental samples?

When researchers encounter signal detection issues with SSO1 antibodies, a systematic troubleshooting approach is recommended:

Antibody validation:

• Test antibody functionality using recombinant SSO1 protein as a positive control

• Verify antibody storage conditions (avoid repeated freeze-thaw cycles)

• Check antibody expiration date and consider ordering a new lot

Sample preparation:

• Ensure complete cell lysis (especially important for yeast cells with rigid cell walls)

• Optimize protein extraction buffer composition:

  • Include appropriate detergents for membrane protein solubilization

  • Use fresh protease inhibitor cocktails

  • Consider non-reducing conditions if epitope contains disulfide bonds

Detection system:

• Use a more sensitive detection reagent (amplified chemiluminescence)

• Increase primary antibody incubation time (overnight at 4°C)

• Enhance signal using biotin-streptavidin amplification systems

• Verify functionality of secondary antibody and detection reagents with positive controls

Expression level:

• Confirm SSO1 expression in your specific yeast strain and growth conditions

• Consider concentrating proteins using immunoprecipitation prior to Western blot analysis

• Use transcriptional analysis (qPCR) to verify SSO1 mRNA expression

How can non-specific background be reduced when using SSO1 antibodies?

High background is a common challenge when working with antibodies. For SSO1 antibodies, consider these specialized approaches:

Blocking optimization:

• Test alternative blocking agents:

  • BSA (0.5-3%) may reduce background compared to milk for some applications

  • Commercial blocking buffers specifically designed for yeast applications

  • Fish gelatin (2-5%) can reduce background in sensitive applications

Washing procedure enhancement:

• Increase washing stringency:

  • Add 0.1-0.5% Tween-20 or 0.1% Triton X-100 to wash buffers

  • Extend wash durations (5 × 10 minutes instead of standard protocol)

  • Include 150-500 mM NaCl in wash buffers to reduce ionic interactions

Antibody optimization:

• Pre-adsorb antibody against knockout/negative samples

• Dilute antibody in blocking buffer containing 5% pre-immune serum

• Filter antibody solution through 0.22 μm membrane before use

• Consider using Fab fragments instead of complete IgG to reduce non-specific binding

Alternative detection strategies:

• Use monovalent detection systems to reduce cross-linking

• Consider directly labeled primary antibodies to eliminate secondary antibody background

• Employ two-color Western blot systems to visualize specific signal against background

How should quantitative differences in SSO1 detection be interpreted in comparative studies?

When analyzing quantitative differences in SSO1 levels across experimental conditions, researchers should consider:

Normalization approaches:

• Use housekeeping proteins (PGK1, tubulin) as loading controls

• Employ total protein normalization using stain-free gels or reversible protein stains

• Include recombinant SSO1 standard curves for absolute quantification

Statistical analysis recommendations:

• Perform at least three biological replicates

• Apply appropriate statistical tests based on data distribution

• Consider both fold-change and statistical significance when interpreting results

Potential confounding factors:

• Cell cycle-dependent expression changes

• Growth phase effects on protein abundance

• Strain background influence on expression levels

• Post-translational modifications affecting antibody recognition

Experimental variables affecting quantification:

• Exposure time effects on linearity of detection

• Membrane stripping and reprobing limitations

• Antibody saturation at high protein concentrations

For robust quantitative analysis, researchers should validate findings using complementary approaches such as qPCR for mRNA levels or fluorescent protein tagging for protein levels.

How can SSO1 antibodies be used to study protein-protein interactions in SNARE complexes?

SSO1 antibodies can provide valuable insights into SNARE complex formation and dynamics through various methodologies:

Co-immunoprecipitation approaches:

• Direct immunoprecipitation:

  • Immobilize SSO1 antibodies on protein A/G beads

  • Incubate with yeast lysates prepared under non-denaturing conditions

  • Elute and analyze precipitated proteins by Western blot for SNARE partners

• Reverse co-immunoprecipitation:

  • Precipitate with antibodies against suspected interaction partners

  • Probe Western blots with SSO1 antibodies

  • Compare results with direct approach to confirm interactions

Proximity-based detection:

• In situ proximity ligation assay (PLA):

  • Use SSO1 antibodies in combination with antibodies against potential interaction partners

  • PLA signal indicates proteins are within ~40 nm of each other

  • Quantify interaction frequency and subcellular localization

Competition studies:

• Use recombinant fragments of SSO1 or interaction partners to compete with native interactions

• Monitor disruption of complex formation using co-immunoprecipitation

• Map interaction domains based on competition efficiency

These approaches can be particularly valuable for understanding how mutations in SNARE proteins affect complex assembly, similar to studies examining how Vps45 mutations affect SNARE interactions in vesicle fusion .

What considerations are important when using SSO1 antibodies for evolutionary studies across yeast species?

Researchers using SSO1 antibodies for cross-species studies should consider:

Epitope conservation analysis:

• Perform sequence alignment of SSO1 homologs across target species

• Identify regions of high conservation that might contain antibody epitopes

• Predict potential cross-reactivity based on epitope conservation

Cross-reactivity validation:

• Test antibody reactivity against purified recombinant homologs from each species

• Perform Western blot analysis of lysates from different yeast species

• Include appropriate controls (knockout strains when available)

Optimization for each species:

• Adjust lysis conditions based on cell wall composition differences

• Modify antibody concentration and incubation times for each species

• Develop species-specific blocking and washing protocols

Interpretation considerations:

• Signal intensity may not directly correlate with protein abundance across species

• Different detection efficiencies may result from epitope variation

• Consider using species-specific internal controls for normalization

When studying evolutionary relationships, researchers might consider examining other SNARE proteins alongside SSO1, such as those documented in Ashbya gossypii , to build a more comprehensive understanding of SNARE complex evolution.